Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Almonacid

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Pharmacoeconomics - Open|July 1, 2026
Cost-Effectiveness of Tezepelumab Versus Omalizumab in Patients with Severe Uncontrolled Allergic Asthma in SpainElena Villamañan, Santiago Quirce, Covadonga Torres, et al.
International Journal of Chronic Obstructive Pulmonary Disease|August 18, 2010
Misdiagnosis of patients receiving inhaled therapies in primary careJosé Luis Izquierdo, Antonio Martín, Pilar de Lucas, et al.
The European Respiratory Journal|November 6, 2020
The impact of COVID-19 on patients with asthmaJosé Luis Izquierdo, Carlos Almonacid, Yolanda González, et al.
Atencion Primaria|October 22, 2022
Current expert opinion and attitudes to optimize telemedicine and achieve control in patients with asthma in post-pandemic era: The COMETA consensusJesús Molina Paris, Carlos Almonacid Sánchez, Marina Blanco-Aparicio, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 8, 2025
Impact of demographics on mepolizumab effectiveness in severe asthma: One-year REALITI-A subanalysis (12/12 words)Geoffrey Chupp, Liam G Heaney, Girolamo Pelaia, et al.
Open Respiratory Archives|July 27, 2023
[Multidisciplinary Consensus for the Monitoring and Control of Asthma Through Telemedicine. The COMETA Project]Carlos Almonacid Sánchez, Marina Blanco Aparicio, Javier Domínguez Ortega, et al.
International Journal of Chronic Obstructive Pulmonary Disease|August 7, 2025
Support Needs of Patients with Chronic Obstructive Pulmonary Disease (COPD) and Asthma Throughout Their Patient Journey: A Qualitative StudyCarlos Almonacid, Raquel Gómez, Ignacio Morán, et al.
Medicina Clinica|July 1, 2004
[A study of bone mineral density in adult patients with cystic fibrosis]Rosa María Girón, Pilar Sánchez Moliní, Carlos Almonacid, et al.
Open Respiratory Archives|October 9, 2023
[Telemedicine and severe asthma in our environment: Views on the experience of professionals and suggestions to make it a reality]Marina Blanco-Aparicio, Carlos Almonacid, Marta Calvín Lamas, et al.
Open Respiratory Archives|February 25, 2025
Innovations and Challenges in Intermediate Respiratory Care Units: Toward Effective Integration into the Hospital SystemBeatriz Jara Chinarro, Laura Pazos Rodriguez, Miguel Cuchí Alfaro, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Pharmacoeconomics - Open|July 1, 2026
Cost-Effectiveness of Tezepelumab Versus Omalizumab in Patients with Severe Uncontrolled Allergic Asthma in SpainElena Villamañan, Santiago Quirce, Covadonga Torres, et al.
International Journal of Chronic Obstructive Pulmonary Disease|August 18, 2010
Misdiagnosis of patients receiving inhaled therapies in primary careJosé Luis Izquierdo, Antonio Martín, Pilar de Lucas, et al.
The European Respiratory Journal|November 6, 2020
The impact of COVID-19 on patients with asthmaJosé Luis Izquierdo, Carlos Almonacid, Yolanda González, et al.
Atencion Primaria|October 22, 2022
Current expert opinion and attitudes to optimize telemedicine and achieve control in patients with asthma in post-pandemic era: The COMETA consensusJesús Molina Paris, Carlos Almonacid Sánchez, Marina Blanco-Aparicio, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 8, 2025
Impact of demographics on mepolizumab effectiveness in severe asthma: One-year REALITI-A subanalysis (12/12 words)Geoffrey Chupp, Liam G Heaney, Girolamo Pelaia, et al.
Open Respiratory Archives|July 27, 2023
[Multidisciplinary Consensus for the Monitoring and Control of Asthma Through Telemedicine. The COMETA Project]Carlos Almonacid Sánchez, Marina Blanco Aparicio, Javier Domínguez Ortega, et al.
International Journal of Chronic Obstructive Pulmonary Disease|August 7, 2025
Support Needs of Patients with Chronic Obstructive Pulmonary Disease (COPD) and Asthma Throughout Their Patient Journey: A Qualitative StudyCarlos Almonacid, Raquel Gómez, Ignacio Morán, et al.
Medicina Clinica|July 1, 2004
[A study of bone mineral density in adult patients with cystic fibrosis]Rosa María Girón, Pilar Sánchez Moliní, Carlos Almonacid, et al.
Open Respiratory Archives|October 9, 2023
[Telemedicine and severe asthma in our environment: Views on the experience of professionals and suggestions to make it a reality]Marina Blanco-Aparicio, Carlos Almonacid, Marta Calvín Lamas, et al.
Open Respiratory Archives|February 25, 2025
Innovations and Challenges in Intermediate Respiratory Care Units: Toward Effective Integration into the Hospital SystemBeatriz Jara Chinarro, Laura Pazos Rodriguez, Miguel Cuchí Alfaro, et al.
Pageof 4